Pentoz Otc 20mg delayed release FC tablet
PDF Leaflet Revision Date: 27 January 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Short term relief of heartburn and hyperacidity.
Dosage (summary)
20 mg once daily for a maximum of 14 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Increased digoxin availability
- Reduced absorption of azole antifungals
- Increased PT/INR with warfarin
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Co-administration with atazanavir
Common side effects
- Headache
- Dizziness
- Gastrointestinal complaints
Counselling Points
- Take before or during breakfast
- Consult doctor if no relief in 2 weeks
- Avoid long-term use without medical advice
Serious warnings
- Risk of Clostridium difficile associated diarrhoea
- Increased risk of bone fractures
- Acute Tubulointerstitial Nephritis
Important Disclaimer
The Pentoz Otc 20mg delayed release FC tablet professional information leaflet below is the property of Dr ReddyãS Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
